Breakdown | ||||
Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|
Income Statement | Total Revenue | |||
189.19B | 208.35B | 241.39B | 157.74B | 105.94B | Gross Profit |
30.24B | 64.06B | 55.10B | 22.86B | 10.18B | EBIT |
12.85B | 46.98B | 44.76B | 15.09B | -346.00M | EBITDA |
27.98B | 43.50B | 59.47B | 32.55B | 14.54B | Net Income Common Stockholders |
381.00M | 15.24B | -1.36B | 7.57B | -20.73B |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | |||
34.52B | 28.59B | 29.77B | 30.96B | 29.53B | Total Assets |
282.23B | 280.29B | 288.12B | 287.27B | 267.65B | Total Debt |
71.55B | 63.08B | 55.49B | 69.79B | 81.93B | Net Debt |
32.34B | 35.33B | 26.30B | 39.11B | 52.73B | Total Liabilities |
203.91B | 194.80B | 205.13B | 196.83B | 182.09B | Stockholders Equity |
59.25B | 70.28B | 67.55B | 75.46B | 71.25B |
Cash Flow | Free Cash Flow | |||
12.00B | 17.75B | 28.86B | 12.72B | -144.00M | Operating Cash Flow |
27.30B | 32.04B | 40.93B | 23.61B | 12.16B | Investing Cash Flow |
-13.25B | -14.87B | -13.71B | -5.69B | -7.86B | Financing Cash Flow |
-7.30B | -13.36B | -28.02B | -18.08B | 3.96B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
73 Outperform | £241.12M | 3.40 | 18.48% | ― | -21.23% | ― | |
61 Neutral | £193.13M | 4.21 | ― | -11.70% | ― | ||
61 Neutral | £53.58B | 183.44 | -1.85% | 6.91% | -9.08% | -113.54% | |
61 Neutral | £2.71B | 21.62 | -2.87% | 12.53% | 29.33% | ― | |
56 Neutral | $6.99B | 3.76 | -4.38% | 5.90% | -0.24% | -48.46% | |
51 Neutral | £158.58M | 17.20 | -3.25% | ― | -28.38% | 90.60% |